These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37840496)

  • 1. Chain Mediation Analysis of the Effects of Nutrition and Cognition on the Association of Apolipoprotein E ɛ4 with Neuropsychiatric Symptoms in Alzheimer's Disease.
    Jiang J; Hong Y; Li W; Wang A; Jiang S; Jiang T; Wang Y; Wang L; Yang S; Ren Q; Zou X; Xu J
    J Alzheimers Dis; 2023; 96(2):669-681. PubMed ID: 37840496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E ɛ4 (APOE ɛ4) Allele is Associated with Long Sleep Duration Among Elderly with Cognitive Impairment.
    Basta M; Zaganas I; Simos P; Koutentaki E; Dimovasili C; Mathioudakis L; Bourbouli M; Panagiotakis S; Kapetanaki S; Vgontzas A
    J Alzheimers Dis; 2021; 79(2):763-771. PubMed ID: 33361595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
    Qian W; Fischer CE; Schweizer TA; Munoz DG
    Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of apolipoprotein E varepsilon4 on rates of cognitive and functional decline in mild cognitive impairment.
    Whitehair DC; Sherzai A; Emond J; Raman R; Aisen PS; Petersen RC; Fleisher AS;
    Alzheimers Dement; 2010 Sep; 6(5):412-9. PubMed ID: 20813342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PICALM Variation Moderates the Relationships of APOE ɛ4 with Alzheimer's Disease Cerebrospinal Biomarkers and Memory Function Among Non-Demented Population.
    Liu YB; Wang XJ; Tan L; Tan CC; Xu W;
    J Alzheimers Dis; 2023; 96(4):1651-1661. PubMed ID: 38007652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive Improvement After Multi-Domain Lifestyle Interventions in an APOE ɛ4 Homozygous Carrier with Mild Cognitive Impairment: A Case Report and Literature Review.
    Miao Y; Cui L; Li J; Chen Y; Xie X; Guo Q
    J Alzheimers Dis; 2022; 89(4):1131-1142. PubMed ID: 35988223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment.
    Cechova K; Andel R; Angelucci F; Chmatalova Z; Markova H; Laczó J; Vyhnalek M; Matoska V; Kaplan V; Nedelska Z; Ward DD; Hort J
    J Alzheimers Dis; 2020; 73(1):247-257. PubMed ID: 31771052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Apolipoprotein E ɛ4 and Risk Factors on Domains of Cognition in Mild Cognitive Impairment and Dementia.
    Han SH; Noh DH; Jo EJ; Kam KY
    J Alzheimers Dis; 2022; 87(3):1181-1188. PubMed ID: 35466935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal analysis of
    Fokuoh E; Xiao D; Fang W; Liu Y; Lu Y; Wang K
    J Genet; 2021; 100():. PubMed ID: 34470924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric Inventory-Questionnaire Assessed Nighttime Behaviors in Cognitively Asymptomatic Patients with Pathologically Confirmed Alzheimer's Disease Predict More Rapid Cognitive Deterioration.
    Atayde AL; Fischer CE; Schweizer TA; Munoz DG
    J Alzheimers Dis; 2022; 86(3):1137-1147. PubMed ID: 35180114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E genotypes and neuropsychiatric symptoms and syndromes in late-onset Alzheimer's disease.
    Panza F; Frisardi V; Seripa D; D'Onofrio G; Santamato A; Masullo C; Logroscino G; Solfrizzi V; Pilotto A
    Ageing Res Rev; 2012 Jan; 11(1):87-103. PubMed ID: 21763789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-AV45 PET and MRI Reveal the Influencing Factors of Alzheimer's Disease Biomarkers in Subjective Cognitive Decline Population.
    Zhao Z; Wang J; Wang Y; Liu X; He K; Guo Q; Xie F; Huang Q; Li Z
    J Alzheimers Dis; 2023; 93(2):585-594. PubMed ID: 37066915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of white matter hyperintensities (WMHs) and apolipoprotein E (APOE) genotypes on cognition in patients with amnestic mild cognitive impairment (aMCI).
    Yoon B; Shim YS; Cheong HK; Kim YD; Lee KO; Hong YJ; Oh YS; Na HR; Kim BC; Choi SH; Yang DW
    Arch Gerontol Geriatr; 2013; 57(3):292-7. PubMed ID: 23688406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
    Bejanin A; Iulita MF; Vilaplana E; Carmona-Iragui M; Benejam B; Videla L; Barroeta I; Fernandez S; Altuna M; Pegueroles J; Montal V; Valldeneu S; Giménez S; González-Ortiz S; Muñoz L; Padilla C; Aranha MR; Estellés T; Illán-Gala I; Belbin O; Camacho V; Wilson LR; Annus T; Osorio RS; Videla S; Lehmann S; Holland AJ; Zetterberg H; Blennow K; Alcolea D; Clarimon J; Zaman SH; Blesa R; Lleó A; Fortea J
    JAMA Neurol; 2021 Aug; 78(8):937-947. PubMed ID: 34228042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
    Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
    Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.